akhil ch Posted June 4, 2021 Share Posted June 4, 2021 How true is this ? https://youtu.be/UzY8FVEcA4c Link to comment Share on other sites More sharing options...
akhil ch Posted June 4, 2021 Author Share Posted June 4, 2021 Not on WHO list? Link to comment Share on other sites More sharing options...
kurnool NTR Posted June 4, 2021 Share Posted June 4, 2021 It is in the process. WHO requires more data from Bharath Biotech to put Covaxin in the Emergency usage list. May take 6 or more months. Link to comment Share on other sites More sharing options...
kurnool NTR Posted June 4, 2021 Share Posted June 4, 2021 Bharath biotech filed for that in April 2021. Link to comment Share on other sites More sharing options...
BalayyaTarak Posted June 4, 2021 Share Posted June 4, 2021 8 minutes ago, kurnool NTR said: Bharath biotech filed for that in April 2021. antey they are doing mass testing on public tilll now ? Link to comment Share on other sites More sharing options...
kurnool NTR Posted June 4, 2021 Share Posted June 4, 2021 1 minute ago, BalayyaTarak said: antey they are doing mass testing on public tilll now ? Basically all COVID vaccines produced in the world are only for emergency use. None is approved. Covaxin just needs more people to be inoculated, so WHO can put it in Emergency list. Link to comment Share on other sites More sharing options...
sskmaestro Posted June 4, 2021 Share Posted June 4, 2021 18 minutes ago, BalayyaTarak said: antey they are doing mass testing on public tilll now ? may be YES Link to comment Share on other sites More sharing options...
Suresh_Ongole Posted June 4, 2021 Share Posted June 4, 2021 1 hour ago, akhil ch said: How true is this ? https://youtu.be/UzY8FVEcA4c It's true. In Dubai and some Arab countries are also not accepting. Link to comment Share on other sites More sharing options...
KING007 Posted June 4, 2021 Share Posted June 4, 2021 WHO recognize ayina vaccines ye anni countries accept chestunnayi, covaxin ki WHO permission inka raledu anukunta Link to comment Share on other sites More sharing options...
JAYAM_NANI Posted June 4, 2021 Share Posted June 4, 2021 I am surprised to see that Bharat Biotech had taken that initiative so late. I think the Chinese vaccine also only got recently approved. WHO queries could be related to anything including clinical study designs etc. Link to comment Share on other sites More sharing options...
uravis Posted June 4, 2021 Share Posted June 4, 2021 Covaxin is not approved as of now, but it will get approved eventually Link to comment Share on other sites More sharing options...
bob9 Posted June 4, 2021 Share Posted June 4, 2021 June lo Covaxin said it will release 3rd phase trail data and submit it for Peer Review. Not sure why they took this long when they are already publishing 78% efficacy from their Trails in their website and official statements. But they are little late on publishing these data to Public. Hopefully by end of June it should be done. Link to comment Share on other sites More sharing options...
Raaz@NBK Posted June 4, 2021 Share Posted June 4, 2021 9 minutes ago, bob9 said: June lo Covaxin said it will release 3rd phase trail data and submit it for Peer Review. Not sure why they took this long when they are already publishing 78% efficacy from their Trails in their website and official statements. But they are little late on publishing these data to Public. Hopefully by end of June it should be done. Under 18 years vaccine trails avi.. Link to comment Share on other sites More sharing options...
JAYAM_NANI Posted June 5, 2021 Share Posted June 5, 2021 20 hours ago, bob9 said: June lo Covaxin said it will release 3rd phase trail data and submit it for Peer Review. Not sure why they took this long when they are already publishing 78% efficacy from their Trails in their website and official statements. But they are little late on publishing these data to Public. Hopefully by end of June it should be done. The key issue here is with the study design and nature of population involved in these studies. You need to align on these designs with various authorities. India wants separate studies done in our country because of which they might have ended up doing Indian studies first. Instead, they could have gone with mulitcountry study aligned on design with various authorities simultaneously which is easy to say but difficult to come up with. Because of CDSCO stand, it is getting difficult for the approval of vaccine manufacturers like Pfizer and Moderna as they seem to not have studies with Indian population. Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.